Notable Analyst Upgrades and Downgrades for Week of October 25 2021

 

Upgrades:

 

Best Buy (NYSE:BBY) was upgraded by equities researchers at Piper Sandler to a "buy" rating in a research note issued to investors on Tuesday, The Fly reports.

Several other research analysts have also issued reports on the company. Telsey Advisory Group increased their price target on Best Buy from $140.00 to $150.00 and gave the stock an "outperform" rating in a report on Wednesday, August 25th. Jefferies Financial Group increased their price target on Best Buy from $136.00 to $145.00 and gave the stock a "buy" rating in a report on Wednesday, August 25th. Wells Fargo & Company upgraded Best Buy to a "buy" rating in a report on Wednesday, August 25th. DA Davidson upgraded Best Buy to a "buy" rating in a report on Wednesday, August 25th. Finally, Bank of America upgraded Best Buy to a "buy" rating and raised their target price for the company from $145.00 to $157.00 in a report on Wednesday, August 25th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $127.53. Read more …

 

Abbott Laboratories (NYSE:ABT) was upgraded by stock analysts at Atlantic Securities from a "neutral" rating to an "overweight" rating in a research report issued on Wednesday, The Fly reports. The firm presently has a $144.00 target price on the healthcare product maker's stock. Atlantic Securities' price target points to a potential upside of 12.39% from the company's current price.

Several other analysts have also commented on ABT. Redburn Partners initiated coverage on Abbott Laboratories in a report on Thursday, October 14th. They issued a "neutral" rating and a $132.28 price objective for the company. Cowen reaffirmed a "buy" rating and issued a $140.00 price objective on shares of Abbott Laboratories in a report on Friday, October 8th. Zacks Investment Research raised Abbott Laboratories from a "strong sell" rating to a "hold" rating and set a $127.00 price objective for the company in a report on Tuesday, August 3rd. Raymond James lifted their price objective on Abbott Laboratories from $128.00 to $134.00 and gave the stock an "outperform" rating in a report on Thursday, October 21st. Finally, Citigroup boosted their price target on Abbott Laboratories from $135.00 to $140.00 and gave the company a "buy" rating in a report on Friday, October 1st. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $134.94. Read more …

 

General Dynamics (NYSE:GD) was upgraded by research analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research note issued to investors on Thursday, PriceTargets.com reports. The brokerage presently has a $230.00 price target on the aerospace company’s stock, up from their prior price target of $220.00. Wells Fargo & Company‘s price target points to a potential upside of 12.82% from the company’s current price.

GD has been the subject of a number of other reports. Zacks Investment Research upgraded shares of General Dynamics from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a report on Thursday, August 5th. Credit Suisse Group boosted their target price on shares of General Dynamics from $182.00 to $198.00 and gave the company a “neutral” rating in a report on Thursday, July 29th. The Goldman Sachs Group upgraded shares of General Dynamics from a “sell” rating to a “neutral” rating and set a $176.00 target price for the company in a report on Thursday, September 23rd. Finally, Cowen restated a “buy” rating on shares of General Dynamics in a report on Monday, August 9th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, General Dynamics has an average rating of “Buy” and a consensus price target of $213.91. Read more …

 

 

Norfolk Southern (NYSE:NSC) was upgraded by research analysts at Bank of America from a “neutral” rating to a “buy” rating in a report issued on Thursday, Analyst Price Targets reports. The brokerage presently has a $325.00 price objective on the railroad operator’s stock, up from their previous price objective of $263.00. Bank of America‘s price objective would suggest a potential upside of 11.45% from the stock’s current price.

A number of other brokerages also recently commented on NSC. Citigroup lowered their price objective on Norfolk Southern from $325.00 to $310.00 and set a “buy” rating for the company in a research note on Wednesday, October 6th. Evercore ISI raised Norfolk Southern from an “in-line” rating to an “outperform” rating and increased their price target for the stock from $301.00 to $303.00 in a research note on Friday, July 9th. Wells Fargo & Company decreased their price target on Norfolk Southern from $318.00 to $312.00 and set an “overweight” rating for the company in a research note on Thursday, October 7th. Finally, Atlantic Securities began coverage on Norfolk Southern in a research note on Monday, July 12th. They issued a “neutral” rating and a $276.00 price target for the company. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $287.57. Read more …

Notable Analyst Upgrades and Downgrades for Week of September 13, 2021

 

Upgrades:

 

Bank of America (NYSE:BAC) was upgraded by stock analysts at Odeon Capital Group from a "hold" rating to a "buy" rating in a research report issued on Monday, The Fly reports. The brokerage presently has a $46.50 price target on the financial services provider's stock. Odeon Capital Group's price target indicates a potential upside of 15.47% from the stock's previous close.

Several other equities research analysts have also commented on the company. Evercore ISI restated a "buy" rating and issued a $43.00 price objective on shares of Bank of America in a research note on Friday, July 2nd. Truist Securities started coverage on Bank of America in a research note on Wednesday, June 2nd. They issued a "buy" rating for the company. Royal Bank of Canada set a $37.69 price objective on Bank of America and gave the stock a "buy" rating in a research note on Wednesday, July 21st. Credit Suisse Group upped their price objective on Bank of America from $46.00 to $47.00 and gave the stock an "outperform" rating in a research note on Friday, July 16th. Finally, Morgan Stanley upped their price objective on Bank of America from $38.00 to $42.00 and gave the stock an "underweight" rating in a research note on Thursday, July 29th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $40.42. Read more …

 

Baxter International (NYSE:BAX) was upgraded by research analysts at Cowen from a “market perform” rating to an “outperform” rating in a research report issued on Monday, The Fly reports. The brokerage presently has a $98.00 price objective on the medical instruments supplier’s stock. Cowen’s price objective suggests a potential upside of 21.11% from the company’s previous close.

BAX has been the topic of a number of other research reports. SVB Leerink reissued a “buy” rating on shares of Baxter International in a report on Sunday, September 5th. Piper Sandler reduced their price target on shares of Baxter International from $85.00 to $82.00 and set a “neutral” rating for the company in a research report on Thursday, July 29th. Stifel Nicolaus decreased their price objective on shares of Baxter International from $95.00 to $90.00 and set a “buy” rating for the company in a research note on Thursday, July 29th. Barclays upgraded Baxter International from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $93.00 to $100.00 in a research report on Friday, September 3rd. Finally, KeyCorp lowered their price objective on Baxter International from $94.00 to $92.00 and set an “overweight” rating on the stock in a report on Monday, August 2nd. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, Baxter International currently has an average rating of “Buy” and an average target price of $91.08. Read more …

 

Canadian Western Bank (TSE:CWB) was upgraded by equities research analysts at Raymond James from a "market perform" rating to an "outperform" rating in a research note issued on Monday, Price Targets.com reports. The firm currently has a C$41.00 price objective on the stock, up from their previous price objective of C$39.25. Raymond James' price target indicates a potential upside of 13.04% from the company's previous close.

CWB has been the subject of a number of other research reports. National Bankshares upped their target price on shares of Canadian Western Bank from C$40.00 to C$41.00 and gave the stock a "sector perform" rating in a research report on Monday, August 30th. Barclays upgraded shares of Canadian Western Bank from a "neutral" rating to an "overweight" rating and set a C$37.00 price objective for the company in a research report on Friday, May 28th. BMO Capital Markets increased their price objective on shares of Canadian Western Bank from C$37.00 to C$41.00 and gave the company a "market perform" rating in a research report on Monday, May 31st. Credit Suisse Group increased their target price on shares of Canadian Western Bank to C$45.00 and gave the company a "sector peform" rating in a research note on Wednesday, September 1st. Finally, CIBC increased their target price on shares of Canadian Western Bank from C$42.00 to C$44.00 and gave the company an "outperform" rating in a research note on Monday, August 30th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Canadian Western Bank presently has a consensus rating of "Buy" and an average target price of C$41.17. Read more …

 

 

Apple (NASDAQ:AAPL) was upgraded by analysts at Oppenheimer to an “outperform” rating in a note issued to investors on Wednesday, The Fly reports. The brokerage currently has a $165.00 price target on the iPhone maker’s stock. Oppenheimer’s target price would indicate a potential upside of 11.40% from the stock’s current price.

AAPL has been the subject of a number of other reports. Jefferies Financial Group started coverage on shares of Apple in a research note on Monday. They issued a “buy” rating and a $175.00 price objective for the company. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Apple from $165.00 to $175.00 and gave the stock a “buy” rating in a report on Wednesday, July 28th. Sanford C. Bernstein reaffirmed a “hold” rating and set a $132.00 price objective on shares of Apple in a report on Tuesday, August 10th. Barclays lifted their price objective on shares of Apple from $134.00 to $142.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 28th. They noted that the move was a valuation call. Finally, Morgan Stanley lifted their target price on shares of Apple from $166.00 to $168.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 28th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twenty-six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $160.88. Read more …

Notable Analyst Upgrades and Downgrades for Week of August 23, 2021

 

Upgrades:

 

Best Buy (NYSE:BBY) was upgraded by equities research analysts at Bank of America to a “buy” rating in a research report issued on Wednesday, The Fly reports.

Several other analysts also recently weighed in on the company. upgraded Best Buy to a “buy” rating and upped their price objective for the stock from $86.00 to $109.00 in a research report on Friday, May 28th. Barclays upped their target price on Best Buy from $121.00 to $135.00 and gave the stock an “overweight” rating in a report on Friday, May 28th. Zacks Investment Research raised Best Buy from a “sell” rating to a “hold” rating and set a $125.00 target price for the company in a report on Wednesday, April 28th. Piper Sandler upped their target price on Best Buy from $140.00 to $144.00 and gave the stock an “overweight” rating in a report on Friday, May 28th. Finally, Telsey Advisory Group upped their target price on Best Buy from $130.00 to $140.00 and gave the stock an “outperform” rating in a report on Friday, May 28th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $122.65. Read more …

 

DICK’S Sporting Goods (NYSE:DKS) was upgraded by Raymond James from an “underperform” rating to a “market perform” rating in a report released on Thursday, Price Targets.com reports.

A number of other equities research analysts have also issued reports on DKS. Argus upped their target price on shares of DICK’S Sporting Goods from $92.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, June 7th. Barclays upped their target price on shares of DICK’S Sporting Goods from $86.00 to $142.00 and gave the company an “overweight” rating in a research note on Thursday, May 27th. Cowen upped their target price on shares of DICK’S Sporting Goods to $150.00 and gave the company an “outperform” rating in a research note on Friday, August 20th. Robert W. Baird increased their price objective on shares of DICK’S Sporting Goods from $100.00 to $135.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Credit Suisse Group increased their price objective on shares of DICK’S Sporting Goods from $72.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, May 27th. Ten research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $112.10. Read more …

 

Ventas (NYSE:VTR) was upgraded by equities research analysts at BMO Capital Markets from an "underperform" rating to a "market perform" rating in a report issued on Thursday, The Fly reports. The brokerage presently has a $60.00 price target on the real estate investment trust's stock. BMO Capital Markets' target price indicates a potential upside of 8.83% from the stock's current price.

Other research analysts have also issued reports about the company. Raymond James raised their target price on Ventas from $61.00 to $65.00 and gave the stock an "outperform" rating in a research report on Tuesday, June 15th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Ventas from $50.00 to $61.00 and gave the stock a "hold" rating in a research note on Thursday, June 3rd. Mizuho reissued a "neutral" rating and issued a $45.00 price target on shares of Ventas in a research note on Wednesday, July 14th. Wolfe Research began coverage on Ventas in a research report on Monday, June 14th. They issued an "outperform" rating and a $71.00 target price for the company. Finally, Scotiabank upped their price target on Ventas from $61.00 to $63.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 1st. Ten investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Ventas presently has an average rating of "Hold" and an average price target of $57.56. Read more …

 

 

Welltower (NYSE:WELL) was upgraded by research analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a research note issued on Thursday, The Fly reports. The brokerage presently has a $100.00 target price on the real estate investment trust’s stock. BMO Capital Markets’ target price suggests a potential upside of 17.80% from the company’s current price.

A number of other research firms also recently weighed in on WELL. Wolfe Research started coverage on Welltower in a research note on Monday, June 14th. They issued an “outperform” rating and a $94.00 price target on the stock. Evercore ISI raised shares of Welltower from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $77.00 to $86.00 in a research note on Monday, June 14th. KeyCorp boosted their price objective on shares of Welltower from $88.00 to $96.00 and gave the stock an “overweight” rating in a report on Wednesday, August 11th. Raymond James increased their target price on shares of Welltower from $92.00 to $95.00 and gave the company a “strong-buy” rating in a report on Thursday, July 1st. Finally, Capital One Financial raised Welltower from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 21st. Seven equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $80.52. Read more …

Notable Analyst Upgrades and Downgrades for Week of August 2, 2021

 

Upgrades:

 

AllianceBernstein (NYSE:AB) was upgraded by investment analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued on Monday, The Fly reports. The brokerage presently has a $54.50 target price on the asset manager’s stock, up from their prior target price of $44.00. Citigroup’s price objective points to a potential upside of 12.91% from the company’s current price.

Several other equities research analysts also recently issued reports on the stock. Sanford C. Bernstein downgraded shares of AllianceBernstein from a “buy” rating to a “neutral” rating in a research report on Friday, April 9th. Keefe, Bruyette & Woods restated a “market perform” rating and set a $42.00 target price on shares of AllianceBernstein in a report on Tuesday, April 13th. Zacks Investment Research cut shares of AllianceBernstein from a “buy” rating to a “hold” rating in a report on Tuesday, July 27th. Finally, Bank of America restated a “neutral” rating and set a $42.00 target price on shares of AllianceBernstein in a report on Thursday, April 15th. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. AllianceBernstein currently has an average rating of “Hold” and a consensus price target of $44.36. Read more …

 

Welltower (NYSE:WELL) was upgraded by equities research analysts at Berenberg Bank from a "hold" rating to a "buy" rating in a note issued to investors on Tuesday, The Fly reports. The brokerage currently has a $100.00 price objective on the real estate investment trust's stock. Berenberg Bank's target price indicates a potential upside of 15.92% from the stock's previous close.

Other equities analysts also recently issued research reports about the company. Wells Fargo & Company boosted their price target on Welltower from $78.00 to $89.00 and gave the stock an "equal weight" rating in a research report on Friday, July 23rd. Mizuho began coverage on Welltower in a research report on Wednesday, July 14th. They set a "neutral" rating and a $68.00 price target on the stock. Morgan Stanley boosted their price target on Welltower from $79.00 to $86.00 and gave the stock an "overweight" rating in a research report on Monday, July 26th. Capital One Financial raised Welltower from an "equal weight" rating to an "overweight" rating in a research report on Friday, May 21st. Finally, Wolfe Research began coverage on Welltower in a research report on Monday, June 14th. They set an "outperform" rating and a $94.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of "Buy" and a consensus price target of $79.67. Read more …

 

Simon Property Group (NYSE:SPG) was upgraded by equities researchers at Bank of America from a "neutral" rating to a "buy" rating in a note issued to investors on Wednesday, The Fly reports.

Several other brokerages have also recently weighed in on SPG. Truist Securities boosted their price objective on Simon Property Group from $102.00 to $130.00 and gave the stock a "hold" rating in a report on Wednesday, June 23rd. UBS Group assumed coverage on Simon Property Group in a report on Thursday, June 3rd. They set a "neutral" rating and a $135.00 price objective for the company. BMO Capital Markets reissued a "hold" rating on shares of Simon Property Group in a report on Thursday, May 20th. Truist upped their price target on Simon Property Group from $102.00 to $130.00 and gave the company a "hold" rating in a research note on Wednesday, June 23rd. Finally, Stifel Nicolaus raised Simon Property Group from a "hold" rating to a "buy" rating and upped their price target for the company from $125.00 to $132.00 in a research note on Monday, July 19th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have issued a buy rating to the company. Simon Property Group has an average rating of "Hold" and an average price target of $128.13. Read more …

 

 

Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at DNB Markets from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, The Fly reports.

NVO has been the topic of a number of other reports. Barclays reiterated an “overweight” rating on shares of Novo Nordisk A/S in a report on Monday, July 19th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Novo Nordisk A/S in a report on Tuesday. Finally, Zacks Investment Research upgraded shares of Novo Nordisk A/S from a “sell” rating to a “hold” rating and set a $91.00 price target on the stock in a report on Tuesday, July 13th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. Novo Nordisk A/S currently has a consensus rating of “Hold” and a consensus price target of $91.00. Read more …

Notable Analyst Upgrades and Downgrades for Week of June 14, 2021

 

Upgrades:

 

Welltower (NYSE:WELL) was upgraded by equities researchers at Evercore ISI from an “in-line” rating to an “outperform” rating in a research note issued on Monday, The Fly reports. The brokerage currently has a $86.00 target price on the real estate investment trust’s stock, up from their previous target price of $77.00. Evercore ISI’s target price suggests a potential upside of 7.93% from the stock’s current price.

Several other brokerages also recently commented on WELL. KeyCorp increased their price objective on shares of Welltower from $75.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, April 15th. Royal Bank of Canada raised shares of Welltower from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $70.00 to $82.00 in a research report on Monday, May 3rd. Bank of America upgraded shares of Welltower from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $73.00 to $78.00 in a report on Tuesday, March 30th. Mizuho increased their target price on Welltower from $60.00 to $70.00 and gave the company a “neutral” rating in a research note on Wednesday, April 28th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Welltower from $76.00 to $80.00 and gave the company a “buy” rating in a report on Thursday, June 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and ten have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $68.76. Read more …

 

W. P. Carey (NYSE:WPC) was upgraded by equities researchers at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a report issued on Tuesday, The Fly reports. The brokerage currently has a $88.00 price target on the real estate investment trust's stock. JPMorgan Chase & Co.'s price target would indicate a potential upside of 13.20% from the stock's current price.

Other research analysts have also issued reports about the stock. Evercore ISI raised shares of W. P. Carey from an "in-line" rating to an "outperform" rating and raised their price target for the company from $77.00 to $80.00 in a research report on Monday, May 3rd. Bank of America reaffirmed an "underperform" rating on shares of W. P. Carey in a research report on Tuesday, April 13th. Finally, Zacks Investment Research raised shares of W. P. Carey from a "sell" rating to a "hold" rating in a research report on Tuesday, April 13th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. W. P. Carey presently has a consensus rating of "Hold" and a consensus target price of $81.00. Read more …

 

Nestlé (OTCMKTS:NSRGY) was upgraded by investment analysts at Exane BNP Paribas from an "underperform" rating to a "neutral" rating in a report issued on Tuesday, The Fly reports.

Several other equities analysts also recently issued reports on the stock. JPMorgan Chase & Co. reissued an "overweight" rating on shares of Nestlé in a research note on Tuesday, June 1st. Morgan Stanley reaffirmed an "overweight" rating on shares of Nestlé in a research note on Friday, April 23rd. Barclays reaffirmed an "overweight" rating on shares of Nestlé in a research note on Friday, April 23rd. Societe Generale reaffirmed a "buy" rating on shares of Nestlé in a research note on Wednesday, April 28th. Finally, Royal Bank of Canada reissued a "sector perform" rating on shares of Nestlé in a research note on Friday, April 23rd. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock currently has an average rating of "Buy" and a consensus price target of $127.00.

Shares of NSRGY opened at $126.72 on Tuesday. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $364.96 billion, a P/E ratio of 28.22, a price-to-earnings-growth ratio of 3.53 and a beta of 0.37. The firm's 50 day moving average price is $120.91. Nestlé has a 1 year low of $104.50 and a 1 year high of $127.45. Read more …

 

 

AT&T (NYSE:T) was upgraded by equities research analysts at Scotiabank from a “sector underperform” rating to a “sector perform” rating in a note issued to investors on Wednesday, Briefing.com reports. The brokerage presently has a $31.00 price objective on the technology company’s stock, up from their previous price objective of $28.00. Scotiabank’s target price would suggest a potential upside of 6.53% from the company’s current price.

A number of other brokerages have also recently issued reports on T. Morgan Stanley cut their price objective on shares of AT&T from $34.00 to $32.00 and set an “equal weight” rating for the company in a research note on Monday, May 24th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of AT&T from $31.00 to $34.00 in a research note on Wednesday, April 28th. UBS Group raised shares of AT&T from a “neutral” rating to a “buy” rating and upped their price objective for the company from $32.00 to $35.00 in a research note on Friday, May 21st. New Street Research upgraded shares of AT&T from a “neutral” rating to a “buy” rating and set a $35.00 price target for the company in a report on Friday, May 21st. Finally, Oppenheimer reiterated a “hold” rating on shares of AT&T in a report on Monday, April 26th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the stock. AT&T has an average rating of “Hold” and an average price target of $31.81. Read more …

 

Week's Most Significant Insider Trades: Week of March 29, 2021

 

Disposals:

 

Accenture plc (NYSE:ACN) COO Johan Deblaere sold 8,000 shares of Accenture stock in a transaction that occurred on Friday, March 26th. The shares were sold at an average price of $280.00, for a total value of $2,240,000.00. Following the sale, the chief operating officer now directly owns 52,579 shares in the company, valued at approximately $14,722,120. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Accenture stock traded down $2.21 during midday trading on Monday, reaching $278.56. The stock had a trading volume of 16,547 shares, compared to its average volume of 2,102,441. The firm’s fifty day simple moving average is $257.88 and its two-hundred day simple moving average is $245.96. Accenture plc has a twelve month low of $148.28 and a twelve month high of $281.30. The firm has a market cap of $183.54 billion, a price-to-earnings ratio of 34.58, a PEG ratio of 3.09 and a beta of 1.08. Read more …

 

Broadcom Inc. (NASDAQ:AVGO) COO Charlie B. Kawwas sold 1,890 shares of the business’s stock in a transaction on Friday, March 26th. The stock was sold at an average price of $469.29, for a total value of $886,958.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Shares of AVGO stock traded down $16.46 during mid-day trading on Tuesday, reaching $456.16. The stock had a trading volume of 2,777,077 shares, compared to its average volume of 2,224,907. The firm has a market capitalization of $186.25 billion, a PE ratio of 72.52, a price-to-earnings-growth ratio of 1.50 and a beta of 1.05. The stock’s 50-day moving average price is $469.91 and its two-hundred day moving average price is $419.25. The company has a current ratio of 1.87, a quick ratio of 1.71 and a debt-to-equity ratio of 1.69. Broadcom Inc. has a 52-week low of $219.68 and a 52-week high of $495.14. Read more …

 

Cisco Systems, Inc. (NASDAQ:CSCO) Director M Michele Burns sold 13,982 shares of Cisco Systems stock in a transaction on Friday, March 26th. The shares were sold at an average price of $51.55, for a total value of $720,772.10. Following the completion of the transaction, the director now owns 70,468 shares in the company, valued at approximately $3,632,625.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

CSCO stock traded down $0.75 during midday trading on Tuesday, reaching $51.77. 22,321,186 shares of the company’s stock traded hands, compared to its average volume of 22,636,520. Cisco Systems, Inc. has a 1-year low of $35.28 and a 1-year high of $52.94. The company has a market cap of $218.56 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 2.54 and a beta of 0.95. The company has a quick ratio of 1.54, a current ratio of 1.59 and a debt-to-equity ratio of 0.25. The company has a 50-day simple moving average of $47.76 and a two-hundred day simple moving average of $43.46. Read more …

 

 

Ross Stores, Inc. (NASDAQ:ROST) Director George Orban sold 3,250 shares of the company’s stock in a transaction dated Wednesday, March 31st. The shares were sold at an average price of $120.17, for a total transaction of $390,552.50. Following the transaction, the director now owns 405,450 shares in the company, valued at approximately $48,722,926.50. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

George Orban also recently made the following trade(s):

On Friday, March 26th, George Orban sold 3,250 shares of Ross Stores stock. The shares were sold at an average price of $120.12, for a total transaction of $390,390.00.

On Wednesday, March 17th, George Orban sold 3,250 shares of Ross Stores stock. The shares were sold at an average price of $123.31, for a total transaction of $400,757.50.

Ross Stores stock traded up $0.60 during midday trading on Friday, hitting $120.51. The stock had a trading volume of 1,370,938 shares, compared to its average volume of 2,175,749. The firm’s fifty day moving average is $119.68 and its two-hundred day moving average is $109.95. The company has a market capitalization of $42.96 billion, a PE ratio of 143.47, a P/E/G ratio of 8.16 and a beta of 0.95. Ross Stores, Inc. has a 52-week low of $74.17 and a 52-week high of $127.08. The company has a current ratio of 1.65, a quick ratio of 1.24 and a debt-to-equity ratio of 0.83. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of January 11, 2021 (Part 1)

 

Upgrades:

 

Walgreens Boots Alliance (NASDAQ:WBA) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating in a report issued on Monday, Anlyst Ratings reports. The firm currently has a $55.00 price objective on the pharmacy operator’s stock, up from their previous price objective of $41.00. Robert W. Baird’s price target would indicate a potential upside of 21.65% from the company’s previous close.

A number of other equities analysts have also weighed in on WBA. Credit Suisse Group initiated coverage on Walgreens Boots Alliance in a research note on Thursday. They set a “neutral” rating and a $42.00 price objective on the stock. Truist Financial boosted their price objective on Walgreens Boots Alliance from $40.00 to $44.00 in a research note on Tuesday, January 5th. Citigroup lowered their price objective on Walgreens Boots Alliance from $43.00 to $40.00 and set a “neutral” rating on the stock in a research note on Friday, October 16th. BidaskClub downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Friday, December 18th. Finally, The Goldman Sachs Group reduced their target price on Walgreens Boots Alliance from $37.00 to $33.00 and set a “sell” rating on the stock in a research report on Tuesday, October 6th. Four investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $43.65. Read more …

 

Exxon Mobil (NYSE:XOM) was upgraded by Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research report issued on Monday, Briefing.com reports. The brokerage presently has a $57.00 price objective on the oil and gas company's stock, up from their previous price objective of $49.00. Morgan Stanley's price target points to a potential upside of 25.38% from the stock's current price.

XOM has been the subject of a number of other research reports. Credit Suisse Group decreased their price target on shares of Exxon Mobil from $47.00 to $37.00 and set a "neutral" rating for the company in a research note on Monday, November 2nd. Truist Financial boosted their price target on shares of Exxon Mobil from $39.00 to $45.00 in a research note on Friday, December 18th. ValuEngine upgraded shares of Exxon Mobil from a "hold" rating to a "buy" rating in a research note on Tuesday, December 1st. Scotiabank upgraded shares of Exxon Mobil from a "sector underperform" rating to a "sector perform" rating and set a $45.00 price target for the company in a research note on Wednesday, September 23rd. Finally, Raymond James restated a "sell" rating on shares of Exxon Mobil in a research note on Friday, September 18th. Four investment analysts have rated the stock with a sell rating, nineteen have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of "Hold" and a consensus target price of $48.30. Read more …

 

Bank of America (NYSE:BAC) was upgraded by equities research analysts at Smith Barney Citigroup from a “neutral” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports.

A number of other analysts also recently commented on the stock. Morgan Stanley downgraded shares of Bank of America from an “overweight” rating to an “underweight” rating in a report on Monday, November 30th. Barclays upped their price target on Bank of America from $33.00 to $39.00 and gave the stock an “overweight” rating in a report on Monday, January 4th. Piper Sandler boosted their price objective on shares of Bank of America from $28.00 to $36.00 and gave the stock an “overweight” rating in a research report on Monday. Credit Suisse Group raised their target price on shares of Bank of America from $31.00 to $36.00 and gave the company an “outperform” rating in a report on Friday, December 11th. Finally, Royal Bank of Canada set a $28.00 price target on shares of Bank of America and gave the company a “buy” rating in a report on Wednesday, October 14th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the company’s stock. Bank of America currently has a consensus rating of “Buy” and a consensus price target of $31.31. Read more …

 

 

The Bank of New York Mellon (NYSE:BK) was upgraded by investment analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a research note issued on Monday, The Fly reports. The brokerage presently has a $57.00 price target on the bank's stock, up from their previous price target of $44.00. Smith Barney Citigroup's price objective suggests a potential upside of 26.78% from the company's previous close.

Other equities analysts have also issued research reports about the company. Barclays increased their target price on The Bank of New York Mellon from $54.00 to $59.00 and gave the company an "overweight" rating in a research note on Monday, January 4th. Bank of America cut The Bank of New York Mellon from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $42.00 to $39.00 in a report on Friday, November 20th. Morgan Stanley upgraded The Bank of New York Mellon from an "underweight" rating to an "equal weight" rating and set a $51.00 target price on the stock in a report on Monday, November 30th. Credit Suisse Group raised their target price on The Bank of New York Mellon from $44.00 to $48.00 and gave the stock an "outperform" rating in a report on Friday, December 11th. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upgraded The Bank of New York Mellon from a "neutral" rating to a "buy" rating and raised their target price for the stock from $44.00 to $57.00 in a report on Monday. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and ten have issued a buy rating to the company's stock. The Bank of New York Mellon currently has an average rating of "Hold" and an average target price of $47.18. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of December 7, 2020

 

Upgrades:

 

AstraZeneca (NYSE:AZN) was upgraded by research analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research note issued on Monday, Briefing.com reports.

Several other brokerages also recently commented on AZN. HSBC upgraded shares of AstraZeneca from a "reduce" rating to a "hold" rating in a report on Wednesday, November 11th. Oddo Bhf upgraded AstraZeneca from a "reduce" rating to a "buy" rating in a research note on Wednesday, September 23rd. Berenberg Bank initiated coverage on AstraZeneca in a report on Tuesday, September 29th. They issued a "buy" rating on the stock. Finally, UBS Group upgraded AstraZeneca from a "sell" rating to a "neutral" rating in a report on Monday, November 30th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of "Buy" and an average price target of $61.00.

AZN stock opened at $53.74 on Monday. The company has a 50 day moving average of $53.58 and a two-hundred day moving average of $54.49. The company has a market cap of $141.05 billion, a price-to-earnings ratio of 64.75, a PEG ratio of 1.63 and a beta of 0.50. AstraZeneca has a 12-month low of $36.15 and a 12-month high of $64.94. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 1.14. Read more …

 

Vodafone Group (NASDAQ:VOD) was upgraded by Redburn Partners from a “neutral” rating to a “buy” rating in a research note issued on Monday, The Fly reports.

VOD has been the topic of a number of other research reports. Zacks Investment Research upgraded Vodafone Group from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a report on Friday, November 20th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Vodafone Group in a report on Wednesday, October 7th. UBS Group reaffirmed a “buy” rating on shares of Vodafone Group in a research note on Wednesday, November 11th. Finally, BidaskClub lowered Vodafone Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, November 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $17.00. Read more …

 

The Unilever Group (NYSE:UN) was upgraded by investment analysts at Investec from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, The Fly reports.

UN has been the topic of a number of other research reports. Zacks Investment Research lowered shares of The Unilever Group from a “buy” rating to a “hold” rating in a report on Friday, November 6th. Credit Suisse Group reissued an “outperform” rating on shares of The Unilever Group in a research note on Monday, August 17th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell initiated coverage on The Unilever Group in a research report on Thursday, November 12th. They issued a “buy” rating for the company. Smith Barney Citigroup assumed coverage on The Unilever Group in a research report on Thursday, November 12th. They set a “buy” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft started coverage on The Unilever Group in a research report on Monday, October 19th. They set a “buy” rating for the company. Four analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $59.50. Read more …

 

 

Chubb (NYSE:CB) was upgraded by investment analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Tuesday, The Fly reports. The firm presently has a $176.00 price objective on the financial services provider's stock, up from their previous price objective of $138.00. Smith Barney Citigroup's price objective points to a potential upside of 15.04% from the stock's previous close.

Other equities analysts have also recently issued reports about the company. Raymond James upgraded Chubb from an "outperform" rating to a "strong-buy" rating and increased their price target for the stock from $150.00 to $180.00 in a report on Tuesday, November 24th. Bank of America upgraded Chubb from an "underperform" rating to a "neutral" rating and increased their price target for the stock from $123.00 to $132.00 in a report on Thursday, October 29th. They noted that the move was a valuation call. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised Chubb from a "neutral" rating to a "buy" rating and upped their target price for the stock from $138.00 to $176.00 in a research report on Tuesday. Morgan Stanley upped their target price on Chubb from $137.00 to $149.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 24th. Finally, MKM Partners upped their target price on Chubb from $150.00 to $180.00 in a research report on Friday, November 27th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Chubb presently has an average rating of "Buy" and a consensus target price of $153.95. Read more …

Notable Analyst Upgrades and Downgrades for Week of November 30, 2020 (Part 1)

 

Upgrades:

 

Wells Fargo & Company (NYSE:WFC) was upgraded by equities researchers at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Monday, The Fly reports.

A number of other research analysts have also recently issued reports on the company. BMO Capital Markets reduced their price objective on Wells Fargo & Company from $35.00 to $31.00 and set a “market perform” rating on the stock in a research note on Friday, October 16th. DA Davidson raised Wells Fargo & Company from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $27.00 to $31.00 in a research note on Thursday, November 19th. ValuEngine raised Wells Fargo & Company from a “hold” rating to a “buy” rating in a research note on Wednesday, November 25th. Odeon Capital Group upgraded shares of Wells Fargo & Company from a “hold” rating to a “buy” rating in a report on Wednesday, September 2nd. Finally, UBS Group upgraded shares of Wells Fargo & Company from a “sell” rating to a “neutral” rating and upped their price target for the company from $21.00 to $24.00 in a report on Friday, September 11th. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and eleven have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $31.30. Read more …

 

AstraZeneca (NYSE:AZN) was upgraded by equities researchers at UBS Group from a "sell" rating to a "neutral" rating in a note issued to investors on Monday, The Fly reports.

Other equities research analysts also recently issued research reports about the company. HSBC raised AstraZeneca from a "reduce" rating to a "hold" rating in a research report on Wednesday, November 11th. Berenberg Bank initiated coverage on AstraZeneca in a research report on Tuesday, September 29th. They set a "buy" rating on the stock. Oddo Bhf raised AstraZeneca from a "reduce" rating to a "buy" rating in a research report on Wednesday, September 23rd. Finally, Morgan Stanley reaffirmed an "equal weight" rating on shares of AstraZeneca in a research report on Monday, November 23rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company's stock. The company currently has a consensus rating of "Hold" and a consensus target price of $61.00.

AZN opened at $52.61 on Monday. AstraZeneca has a 12-month low of $36.15 and a 12-month high of $64.94. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 1.14. The business's fifty day simple moving average is $53.81 and its 200-day simple moving average is $54.53. The company has a market capitalization of $138.08 billion, a price-to-earnings ratio of 63.39, a PEG ratio of 1.63 and a beta of 0.50. Read more …

 

The Bank of New York Mellon (NYSE:BK) was upgraded by investment analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating in a note issued to investors on Monday, The Fly reports.

Several other equities analysts have also recently commented on the stock. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell cut shares of The Bank of New York Mellon from a "buy" rating to a "neutral" rating in a report on Tuesday, November 10th. Deutsche Bank Aktiengesellschaft upgraded shares of The Bank of New York Mellon from a "hold" rating to a "buy" rating and boosted their price target for the company from $39.00 to $46.00 in a report on Wednesday, November 11th. Smith Barney Citigroup cut shares of The Bank of New York Mellon from a "buy" rating to a "neutral" rating in a report on Tuesday, November 10th. Bank of America cut shares of The Bank of New York Mellon from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $42.00 to $39.00 in a report on Friday, November 20th. Finally, Keefe, Bruyette & Woods cut shares of The Bank of New York Mellon from an "outperform" rating to a "market perform" rating and lowered their price target for the company from $47.00 to $43.00 in a report on Wednesday, November 18th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company's stock. The Bank of New York Mellon has a consensus rating of "Hold" and an average target price of $44.56. Read more …

 

 

U.S. Bancorp (NYSE:USB) was upgraded by investment analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a research note issued on Monday, The Fly reports.

USB has been the subject of a number of other research reports. Bank of America raised shares of U.S. Bancorp from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $39.00 to $41.00 in a research report on Wednesday, October 7th. JPMorgan Chase & Co. raised their price target on shares of U.S. Bancorp from $37.50 to $43.50 and gave the stock an “underweight” rating in a research report on Tuesday, October 6th. ValuEngine raised shares of U.S. Bancorp from a “sell” rating to a “hold” rating in a report on Monday, November 2nd. Finally, TheStreet raised shares of U.S. Bancorp from a “c” rating to a “b-” rating in a report on Thursday, October 15th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company. U.S. Bancorp presently has a consensus rating of “Hold” and a consensus target price of $44.58. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of May 11, 2020

Upgrades:

Canadian Natural Resources (NYSE:CNQ) (TSE:CNQ) was upgraded by investment analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research note issued to investors on Thursday, The Fly reports. The firm currently has a $21.00 price objective on the oil and gas producer’s stock, up from their prior price objective of $15.00. Goldman Sachs Group’s price target would suggest a potential upside of 30.52% from the stock’s previous close.

A number of other brokerages have also commented on CNQ. Wood & Company reaffirmed a “hold” rating on shares of Canadian Natural Resources in a report on Friday, January 31st. UBS Group decreased their price objective on Canadian Natural Resources from $55.00 to $28.00 and set a “buy” rating on the stock in a report on Tuesday, March 31st. JPMorgan Chase & Co. decreased their price objective on Canadian Natural Resources from $44.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, March 11th. Royal Bank of Canada upped their price objective on Canadian Natural Resources from $24.00 to $27.00 and gave the company an “outperform” rating in a report on Friday, May 8th. Finally, Raymond James reissued a “buy” rating on shares of Canadian Natural Resources in a report on Friday, March 6th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $34.09. Read more …

Leggett & Platt (NYSE:LEG) was upgraded by analysts at Raymond James from a “market perform” rating to a “strong-buy” rating in a research note issued on Thursday, MarketBeat reports. The brokerage presently has a $32.00 target price on the stock. Raymond James’ target price points to a potential upside of 27.54% from the stock’s current price.

Several other equities research analysts also recently commented on LEG. TheStreet downgraded Leggett & Platt from a “b” rating to a “c+” rating in a report on Friday, March 6th. Zacks Investment Research downgraded Leggett & Platt from a “hold” rating to a “sell” rating and set a $28.00 price objective for the company. in a report on Wednesday, April 1st. Stifel Nicolaus decreased their price objective on Leggett & Platt from $49.00 to $20.00 and set a “hold” rating for the company in a report on Monday, April 6th. Piper Sandler cut their target price on Leggett & Platt from $47.00 to $35.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Finally, SunTrust Banks cut their target price on Leggett & Platt from $29.00 to $27.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a strong buy rating to the stock. Leggett & Platt has a consensus rating of “Hold” and an average target price of $32.67. Read more …

Yum! Brands (NYSE:YUM) was upgraded by Stifel Nicolaus from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, The Fly reports.

Several other analysts have also recently issued reports on the company. UBS Group cut their target price on Yum! Brands from $109.00 to $105.00 and set a “buy” rating for the company in a research report on Thursday, April 30th. Credit Suisse Group increased their target price on Yum! Brands from $79.00 to $84.00 and gave the stock a “neutral” rating in a research report on Thursday, April 30th. Morgan Stanley increased their target price on Yum! Brands from $80.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, April 30th. BTIG Research cut Yum! Brands from a “buy” rating to a “neutral” rating in a research report on Friday, February 7th. Finally, Wells Fargo & Co raised their price target on Yum! Brands from $85.00 to $94.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. One investment analyst has rated the stock with a sell rating, eighteen have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $99.14. Read more …

Omega Healthcare Investors (NYSE:OHI) was upgraded by investment analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research note issued on Friday, MarketBeat.com reports. The firm currently has a $34.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $32.00. Raymond James’ price target would indicate a potential upside of 29.23% from the company’s current price.

Several other brokerages also recently commented on OHI. Zacks Investment Research upgraded shares of Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research report on Thursday, April 23rd. Capital One Financial raised shares of Omega Healthcare Investors from an “equal weight” rating to an “overweight” rating and set a $33.00 price objective on the stock in a research report on Tuesday, May 5th. Wells Fargo & Co lowered their target price on shares of Omega Healthcare Investors from $43.00 to $28.00 and set an “equal weight” rating on the stock in a report on Thursday, March 26th. Citigroup decreased their price objective on shares of Omega Healthcare Investors from $44.00 to $25.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Finally, SunTrust Banks decreased their price target on shares of Omega Healthcare Investors from $36.00 to $32.00 and set a “hold” rating for the company in a research note on Thursday, April 23rd. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $35.10. Read more …